These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6143881)

  • 21. Surfactant therapy and nasal CPAP for newborns with RDS.
    Chugh K
    Indian Pediatr; 1995 Apr; 32(4):513-4. PubMed ID: 8635825
    [No Abstract]   [Full Text] [Related]  

  • 22. [Factors affecting clinical response to surfactant therapy in neonates with severe respiratory distress syndrome].
    Fujiwara T; Chida S; Konishi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):29-34. PubMed ID: 2041254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New avenues in surfactant research.
    Robertson B
    Z Geburtshilfe Neonatol; 2001; 205(3):77-8. PubMed ID: 11474993
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome.
    Morley CJ
    Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Untapped therapeutic potential of surfactant proteins: is there a case for recombinant SP-D supplementation in neonatal lung disease?
    Clark HW
    Neonatology; 2010 Jun; 97(4):380-7. PubMed ID: 20551708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant for the treatment of respiratory distress syndrome.
    Jobe A; Ikegami M
    Am Rev Respir Dis; 1987 Nov; 136(5):1256-75. PubMed ID: 3314618
    [No Abstract]   [Full Text] [Related]  

  • 27. Inactivation of pulmonary surfactant and the treatment of acute lung injuries.
    Taeusch HW; Keough KM
    Pediatr Pathol Mol Med; 2001; 20(6):519-36. PubMed ID: 11699577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the treatment of the respiratory distress syndrome in premature infants with tris(hydroxymethyl)-aminomethane (THAM) and wetting agents].
    Jarre W; Ketterle W; Reinwein H
    Helv Paediatr Acta; 1965 Apr; 20(1):27-39. PubMed ID: 5828973
    [No Abstract]   [Full Text] [Related]  

  • 29. Innovation in surfactant therapy I: surfactant lavage and surfactant administration by fluid bolus using minimally invasive techniques.
    Dargaville PA
    Neonatology; 2012; 101(4):326-36. PubMed ID: 22940622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory distress syndrome and intracranial hemorrhage: cause or association? Inferences from surfactant clinical trials.
    Leviton A; VanMarter L; Kuban KC
    Pediatrics; 1989 Nov; 84(5):915-22. PubMed ID: 2677963
    [No Abstract]   [Full Text] [Related]  

  • 31. Pre- and postnatal factors in chronic lung disease: implications for management.
    Martin RJ; Walsh MC
    Paediatr Respir Rev; 2004; 5 Suppl A():S235-40. PubMed ID: 14980277
    [No Abstract]   [Full Text] [Related]  

  • 32. Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome.
    Hammoud M; Al-Kazmi N; Alshemmiri M; Thalib L; Ranjani VT; Devarajan LV; Elsori H
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):167-75. PubMed ID: 15280142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulatory properties of surfactant preparations.
    Bersani I; Kunzmann S; Speer CP
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):99-110. PubMed ID: 23428105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances with surfactant.
    Turell DC
    Emerg Med Clin North Am; 2008 Nov; 26(4):921-8, viii. PubMed ID: 19059091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn Respiratory Distress.
    Hermansen CL; Mahajan A
    Am Fam Physician; 2015 Dec; 92(11):994-1002. PubMed ID: 26760414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
    Mazela J; Merritt TA; Gadzinowski J; Sinha S
    Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surfactant replacement in neonatal and adult respiratory distress syndrome.
    Robertson B
    Eur J Anaesthesiol; 1984 Dec; 1(4):335-43. PubMed ID: 6549536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nursing aspects in the treatment of respiratory distress syndrome].
    Meyer A; Günther S
    Kinderkrankenschwester; 1995 Mar; 14(3):115-6. PubMed ID: 7703162
    [No Abstract]   [Full Text] [Related]  

  • 39. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
    Robertson B
    Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.